#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Breast cancer metastatic Type 2 diabetes mellitus Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Adrenogenital syndrome Brain stem glioma Chondrosarcoma Chronic myeloid leukaemia (in remission) Cerebral amyloid angiopathy Demyelination Neurodevelopmental disorder B-cell lymphoma recurrent Aspergillus infection Diffuse large B-cell lymphoma Acromegaly Fibrous dysplasia of bone Adrenocortical carcinoma Transplant rejection Essential thrombocythaemia More trials…

    Learn about Rare Diseases

    Encephalitis autoimmune – Treatment Advanced systemic mastocytosis – Basic Information Mantle cell lymphoma stage IV – Basic Information Isodicentric chromosome 15 syndrome – Diagnostics Haemophilia A with anti factor VIII – Treatment Crigler-Najjar syndrome – Trials in Disease Wiskott-Aldrich syndrome – Treatment Noonan syndrome – Life with Disease Erdheim-Chester disease – Treatment Urea cycle disorder – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Bjt-778 Opelconazole Aluminium Oxide Ociperlimab Gozetotide Alf-18 APAZUNERSEN LUTETIUM LU-177 AB521 Tinlarebant Tpst-1120 Candesartan Pyridoxine Cytarabine Temocillin Sodium Zopiclone Colesevelam Human Apotransferrin Etrinabdione Panobinostat Acetylsalicylic Acid Ph. Eur. More therapies…

    Learn about Your Condition

    Oesophageal achalasia Autoimmune uveitis Aortic aneurysm Mantle cell lymphoma Pouchitis Anogenital warts Cutaneous sarcoidosis Brain neoplasm Myxofibrosarcoma Malignant melanoma stage IV Thymic carcinoma Procedural hypotension Glioma Optic ischaemic neuropathy Hyperkalaemia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Centre Hospitalier Universitaire De La Reunion

Centre Hospitalier Universitaire De La Reunion

Allee Des Topazes, Cs 11021, St Denis, 97400, France

Want to learn more about this study or check if you can participate? Contact us.

  • Study on the Effect of Rocuronium Bromide, Sugammadex, and Suxamethonium Chloride for Adults with Respiratory Distress Requiring Emergency Tracheal Intubation

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Respiratory distress
    Investigated Drugs:
    • Sugammadex
    • Suxamethonium Chloride
    • Rocuronium Bromide
    France
  • Study on Milrinone for Preventing Delayed Brain Ischemia in Patients with Severe Subarachnoid Hemorrhage

    Recruiting

    3 1 1
    Investigated Diseases:
    • Subarachnoid haemorrhage
    Investigated Drugs:
    • Milrinone
    • Glucose Monohydrate
    France
  • Study on Long-Term Safety of Cenerimod for Adults with Moderate-to-Severe Systemic Lupus Erythematosus

    Recruiting

    3 1 1
    Investigated Drugs:
    • Cenerimod
    Bulgaria Czechia France Germany Greece Poland +3
  • Study on Medulloblastoma Treatment in Children Aged 3-5 Using Carboplatin and Drug Combination

    Recruiting

    4 1 1 1
    Investigated Drugs:
    • Lomustine
    • Carboplatin
    • Cisplatin
    Austria Belgium Czechia Finland France Germany +4
  • Study of CAPOX or FOLFOX chemotherapy before surgery in patients with obstructive colon cancer treated with colostomy

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Colon cancer
    Investigated Drugs:
    • Levoleucovorin
    • Capecitabine
    • Fluorouracil
    France
  • Study on Ependymoma Treatment in Children, Adolescents, and Young Adults Using Cisplatin, Cyclophosphamide, Etoposide, and a Drug Combination

    Recruiting

    4 1 1 1
    Investigated Diseases:
    • Ependymoma
    Investigated Drugs:
    • Sodium Valproate
    • Cisplatin
    • Cyclophosphamide
    Austria Belgium Czechia Denmark Finland France +7
  • Study of drug combinations including irinotecan, ifosfamide, vincristine, dactinomycin, regorafenib and other agents for children and adults with rhabdomyosarcoma

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Rhabdomyosarcoma
    Investigated Drugs:
    • Dactinomycin
    • Vinorelbine Tartrate
    • Ifosfamide
    Austria Belgium Czechia Denmark Finland France +10
  • Study on High-Risk Neuroblastoma Treatment with Busulfan, Melphalan, and Drug Combination for Patients with Insufficient Metastatic Response

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Busulfan
    • Dinutuximab Beta
    • Irinotecan Hydrochloride Trihydrate
    Austria Belgium Czechia Denmark Finland France +13
  • Study on Short vs. Long Antiplatelet Therapy with Aspirin for Adults After TAVI for Symptomatic Aortic Stenosis

    Recruiting

    4 1 1 1
    Investigated Diseases:
    • Aortic valve stenosis
    Investigated Drugs:
    • Acetylsalicylic Acid
    • D,L-Lysine Acetylsalicylate
    France
  • Study on Reducing HIV-HBV Treatment with Darunavir, Ritonavir, and Lamivudine for Patients with Controlled Co-Infection

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • HIV infection
    Investigated Drugs:
    • Darunavir
    • Ritonavir
    • Dolutegravir Sodium
    France
Previous Page
1 2 3 4 … 7
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.

Numer nieprawidłowy!
Numer nieprawidłowy!